CD44<sup>+</sup>/CD24<sup>-</sup> phenotype contributes to malignant relapse following surgical resection and chemotherapy in patients with invasive ductal carcinoma
<p>Abstract</p> <p>Background</p> <p>Invasive ductal carcinoma is the most common type of breast malignancy, with varying molecular features and resistance to treatment. Although CD44+/CD24- cells are believed to act as breast cancer stem cells and to be linked to poor...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2012-07-01
|
| Series: | Journal of Experimental & Clinical Cancer Research |
| Online Access: | http://www.jeccr.com/content/31/1/59 |